课题基金 / 基金详情

SPECIFICITY OF INTERCALATION REACTIONS

SPECIFICITY OF INTERCALATION REACTIONS
插层反应的特异性
批准号:
3173227
负责人:
Jonathan B. CHAIRES
金额:
$4.94万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-03-01 至 1987-02-28

项目摘要

项目成果

Jonathan B. CHAIRES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A wide variety of compounds bind to DNA by intercalation. While the average affinity of these intercalators for DNA is similar, not all intercalators are effective in the treatment of cancer. The molecular basis for this behavior is sought. What makes an intercalating compound an effective cancer drug? My hypothesis is that the intercalators effective in cancer chemotherapy recognize some feature of the DNA in proliferating cells that the less effective intercalators do not, either a particular DNA conformation or sequence. Previous work on the cancer drug daunomycin indicated that one possible distinguishing trait is the ability to discriminate "free" DNA from DNA structured into nucleosomes. The proposed research will explore the nucleosome as a drug receptor in three ways. First, the binding of a wide variety of intercalators to "free" DNA and to nucleosomes will be studied, to see if the clinically effective compounds show discriminating behavior analogous to daunomycin. Second, stopped-flow and temperature-jump studies will be used to develop plausible reaction mechanisms for the binding of ethidium and daunomycin to nucleosomes. Finally, photochemical crosslinking experiments will be performed to localize drug binding sites within the nucleosomal DNA, in order to establish if all possible intercalation sites are freely accessible. In a separate aspect of the proposed research, the sequence specificity of anthracycline antibiotics widely used in cancer chemotherapy, will be explored using photochemical crosslinking, modern "footprinting" techniques, and affinity chromatography. Finally, the influence of intercalators on the B to Z transition will be studied, to define the role of intercalators as allosteric effectors of DNA conformational changes. The information obtained from these studies will enhances our fundamental understanding of an important class of ligand-DNA interactions, and should provide a foundation for the rational design of new chemotherapeutic compounds of greater specificity and potency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COBRE: LOUISVILLE RES FOUND INC: CORE E: BIOPHYSICAL FACILITY
  • 批准号:
    8360671
  • 项目类别:
  • 资助金额:
    $10.78万
  • 财政年份:
    2011
  • 负责人:
    Jonathan B. CHAIRES
  • 依托单位:
COBRE: LOUISVILLE RES FOUND INC: CORE E: BIOPHYSICAL FACILITY
  • 批准号:
    8167784
  • 项目类别:
  • 资助金额:
    $10.89万
  • 财政年份:
    2010
  • 负责人:
    Jonathan B. CHAIRES
  • 依托单位:
COBRE: LOUISVILLE RES FOUND INC: CORE E: BIOPHYSICAL FACILITY
  • 批准号:
    7959812
  • 项目类别:
  • 资助金额:
    $5.28万
  • 财政年份:
    2009
  • 负责人:
    Jonathan B. CHAIRES
  • 依托单位:
Targeting Nucleic Acids with an Integrated Vitural and Actual Screen
  • 批准号:
    7194426
  • 项目类别:
  • 资助金额:
    $28.75万
  • 财政年份:
    2007
  • 负责人:
    Jonathan B. CHAIRES
  • 依托单位:
海外基金